Stockscreener 앱 받기
10.45
1.85%
0.19
시간 외 거래:
10.25
-0.20
-1.91%
전일 마감가:
$10.26
열려 있는:
$10.26
하루 거래량:
619.41K
Relative Volume:
0.75
시가총액:
$369.03M
수익:
$2.07M
순이익/손실:
$-47.68M
주가수익비율:
-3.7057
EPS:
-2.82
순현금흐름:
$-31.31M
1주 성능:
+2.96%
1개월 성능:
+6.85%
6개월 성능:
-17.65%
1년 성능:
-17.46%
1일 변동 폭
$10.13
$10.60
1주일 범위
$9.69
$10.60
52주 변동 폭
$8.12
$18.23
Delcath Systems Inc Stock (DCTH) Company Profile
명칭
Delcath Systems Inc
전화
(518) 743-8892
주소
566 QUEENSBURY AVENUE, QUEENSBURY, NY
DCTH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
10.45 | 362.32M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
127.78 | 219.88B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.79 | 141.54B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
366.39 | 133.39B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.31 | 124.82B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.85 | 48.84B | 5.88B | 1.34B | 799.60M | 2.3489 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-28 | 개시 | Craig Hallum | Buy |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2022-07-26 | 재개 | Canaccord Genuity | Buy |
| 2021-12-10 | 개시 | H.C. Wainwright | Buy |
| 2021-03-09 | 개시 | Canaccord Genuity | Buy |
| 2021-01-05 | 개시 | BTIG Research | Buy |
| 2020-06-01 | 개시 | Laidlaw | Buy |
모두보기
Delcath Systems Inc 주식(DCTH)의 최신 뉴스
Under the Radar: 3 Microcap Growers Passing a Tough Test - Benzinga
(DCTH) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Should New HEPZATO Subgroup Data and Delcath’s Targeted Strategy Require Action From DCTH Investors? - Yahoo Finance
Delcath Systems Inc Stock Analysis and ForecastLong-Term Growth Stocks & Fast Growing Investment Plans - earlytimes.in
Hepzato Kit Safe, Effective in Metastatic, Unresectable Uveal Melanoma - Cure Today
Are Options Traders Betting on a Big Move in Delcath Systems Stock? - Yahoo Finance
Delcath Systems publishes results from subgroup analyses of FOCUS study - Yahoo Finance
Delcath’s HEPZATO shows consistent efficacy across patient subgroups By Investing.com - Investing.com Nigeria
Delcath’s HEPZATO shows consistent efficacy across patient subgroups - Investing.com India
Delcath Systems (DCTH) Reveals Key Findings from FOCUS Study Sub - GuruFocus
Which metastatic uveal melanoma patients gain most from a liver-directed drug? - Stock Titan
Simplify Asset Management Inc. Increases Stock Position in Delcath Systems, Inc. $DCTH - MarketBeat
Glenmark Pharmaceuticals Limited (532296) Gets Regulatory ApprovalFibonacci Extensions & Build Wealth With Strategy - bollywoodhelpline.com
Book value per share of Delcath Systems, Inc. – MUN:DV3R - TradingView — Track All Markets
Bearish Setup: Is Delcath Systems Inc stock a smart buy before Fed meetingTrade Entry Summary & Advanced Technical Signal Analysis - moha.gov.vn
Precision Trading with Delcath Systems Inc. (DCTH) Risk Zones - Stock Traders Daily
Delcath Systems, Inc. (NASDAQ:DCTH) is a favorite amongst institutional investors who own 51% - Yahoo Finance
Delcath Systems (STU:DV3R) EV-to-OCF : 19.88 (As of Dec. 21, 2025) - GuruFocus
Why Delcath Systems Inc. (DV3R) stock stays on buy lists2025 Biggest Moves & Entry Point Strategy Guides - bolumsonucanavari.com
Delcath Systems Earnings Notes - Trefis
Delcath Systems authorizes $25 million share repurchase program - MSN
Can Delcath Systems Inc. (DV3R) stock hold up in economic slowdownCEO Change & Risk Controlled Daily Trade Plans - Bölüm Sonu Canavarı
Do Options Traders Know Something About Delcath Systems Stock We Don't? - MSN
Will Delcath Systems Inc. (DV3R) stock sustain bullish trend into 2025Inflation Watch & Long-Term Safe Return Strategies - DonanımHaber
Is Delcath Systems Inc. stock a safe haven assetPortfolio Return Report & Reliable Intraday Trade Plans - Улправда
Will Delcath Systems Inc. stock sustain high P E ratiosPortfolio Profit Report & Expert-Curated Trade Recommendations - Улправда
Delcath Systems, Inc. (NASDAQ:DCTH) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Here’s What Hit Delcath Systems (DCTH) in Q3 - Insider Monkey
How Delcath Systems Inc. (DCTH) Affects Rotational Strategy Timing - Stock Traders Daily
Vivo Capital LLC Decreases Stake in Delcath Systems, Inc. $DCTH - MarketBeat
Delcath Systems, Inc. (DCTH) Misses Q1 Earnings Estimates - sharewise.com
How higher bond yields impact Delcath Systems Inc. (DV3R) stock2025 Key Highlights & High Conviction Investment Ideas - Newser
Analysts Offer Insights on Healthcare Companies: Delcath Systems (DCTH) and Champions Oncology (CSBR) - The Globe and Mail
How Delcath Systems Inc. (DV3R) stock reacts to Fed tighteningPortfolio Risk Summary & Daily Stock Trend Watchlist - Newser
Why Delcath Systems Inc. (DV3R) stock trades below fair valueQuarterly Trade Report & Daily Stock Trend Reports - Newser
Delcath Systems Announces Publication of 10-Year Single-Center Experience with Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma - BioSpace
Delcath reports 29-month survival in liver cancer treatment study - Investing.com India
Delcath reports 29-month survival in liver cancer treatment study By Investing.com - Investing.com Nigeria
Delcath Systems (DCTH) Showcases Promising Study Results for Liv - GuruFocus
Is Delcath Systems Inc. stock a top pick in earnings seasonJuly 2025 Market Mood & Real-Time Volume Trigger Notifications - Newser
Investors in Delcath Systems (NASDAQ:DCTH) have seen splendid returns of 221% over the past three years - Yahoo Finance
(DCTH) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
Delcath Systems (DCTH) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Delcath Systems (DCTH) is on the Move, Here's Why the Trend Could be Sustainable - MSN
Delcath Systems (DCTH) Competitors and Alternatives 2025 - MarketBeat
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Dir Sylvester Buys 4,386 ($39K) Of Delcath Sys Inc [DCTH] - TradingView
DCTH insider Form 4 shows director purchase and 14,936-share stake - Stock Titan
Delcath Systems Inc (DCTH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.82%
자본화:
|
볼륨(24시간):